Skip to main content
Jonathan Day, MD, Internal Medicine, Rochester, MN

JonathanDayMDPharmD

Internal Medicine Rochester, MN

Hematology/Oncology

Fellow Physician

Dr. Day is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Day's full profile

Already have an account?

  • Office

    200 First St SW
    Rochester, MN 55905

Education & Training

  • Mayo Clinic
    Mayo ClinicResidency, 2027
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2020 - 2024
  • Southern Illinois University School of Medicine
    Southern Illinois University School of MedicineClass of 2020
  • St. Louis College of Pharmacy
    St. Louis College of PharmacyPharmD, Magna Cum Laude, 2008 - 2014

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2024 - 2025
  • IA State Medical License
    IA State Medical License 2020 - 2024

Awards, Honors, & Recognition

  • François M. Abboud Resident Research Award University of Iowa Department of Internal Medicine, 2023
  • Graduate Medical Education Excellence in Clinical Teaching Award University of Iowa GME, 2021-2023

Publications & Presentations

PubMed

Books/Book Chapters

Abstracts/Posters

  • Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO Consortium
    Jonathan R Day, Melissa C. Larson, Carla Casulo, Yucai Wang, Dai Chihara, Brad S. Kahl, Peter Martin, Izidore S. Lossos, Victor M. Orellana-Noia, Richard Burack, Jonat..., ASH 2022, New Orleans, LA; Blood (2022) 140 (Supplement 1): 6642–6644., 12/10/2022
  • Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry
    David A. Bond, Jason T. Romancik, Jeffrey M. Switchenko, Brielle Berkowitz, Jonathan R Day, Umar Farooq, Sabarish Ayyappan, Katelin Baird, Michelle L. Churchman, Andre..., ASH 2022;, Blood (2022) 140 (Supplement 1): 6509–6511., 12/10/2022
  • Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.
    Casulo C, Larson MC, Day JR, Habermann TM, Lossos IS, Wang Y, Nastoupil LJ, Strouse C, Chihara D, Martin P, Cohen JB, Kahl BS, Burack WR, Koff JL, Friedberg JW, Cerhan..., Journal of Clinical Oncology / ASCO, Chicago, IL, 6/4/2022
  • Join now to see all